21Shares just submitted its Form 8-A filing for its spot XRP ETF, triggering a mandatory 20-day SEC review period.
The move advances the proposal toward a potential listing on the Cboe BZX Exchange unless the SEC objects.
The ETF would track XRP’s spot price using the CME CF XRP-Dollar Reference Rate, with the ticker TOXR.
The fund’s custodians are Coinbase Custody, Anchorage Digital Bank and BitGo, with assets remaining in segregated cold storage.
Several more issuers, including Bitwise Canary Capital, VanEck, Invesco Galaxy, and Grayscale have applied for spot XRP ETFs, with SEC decisions anticipated by the end of the year.
The price of XRP has surged in the last 24 hours along with the rest of the crypto market. At time of publishing, XRP is up 9% in the last day, at $2.46.
Follow us on X, Facebook and Telegram
Don't Miss a Beat – Subscribe to get email alerts delivered directly to your inbox
Check Price Action
Surf The Daily Hodl Mix
Disclaimer: Opinions expressed at The Daily Hodl are not investment advice. Investors should do their due diligence before making any high-risk investments in Bitcoin, cryptocurrency or digital assets. Please be advised that your transfers and trades are at your own risk, and any losses you may incur are your responsibility. The Daily Hodl does not recommend the buying or selling of any cryptocurrencies or digital assets, nor is The Daily Hodl an investment advisor. Please note that The Daily Hodl participates in affiliate marketing.
Generated Image: Midjourney
The post 21Shares Triggers 20-Day Clock for Spot XRP ETF Approval appeared first on The Daily Hodl.
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.